Literature DB >> 19907440

Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.

E Chapiro, L Russell, E Lainey, S Kaltenbach, C Ragu, V Della-Valle, K Hanssens, E A Macintyre, I Radford-Weiss, E Delabesse, H Cavé, T Mercher, C J Harrison, F Nguyen-Khac, P Dubreuil, O A Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19907440     DOI： 10.1038/leu.2009.231

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  24 in total

1.  Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  I-Ming Chen; Richard C Harvey; Charles G Mullighan; Julie Gastier-Foster; Walker Wharton; Huining Kang; Michael J Borowitz; Bruce M Camitta; Andrew J Carroll; Meenakshi Devidas; D Jeanette Pullen; Debbie Payne-Turner; Sarah K Tasian; Shalini Reshmi; Catherine E Cottrell; Gregory H Reaman; W Paul Bowman; William L Carroll; Mignon L Loh; Naomi J Winick; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2012-02-24       Impact factor: 22.113

2.  Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

Authors:  Diederik van Bodegom; Jun Zhong; Nadja Kopp; Chaitali Dutta; Min-Sik Kim; Liat Bird; Oliver Weigert; Jeffrey Tyner; Akhilesh Pandey; Akinori Yoda; David M Weinstock
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

Review 3.  The biology of thymic stromal lymphopoietin (TSLP).

Authors:  Steven F Ziegler; Florence Roan; Bryan D Bell; Thomas A Stoklasek; Masayuki Kitajima; Hongwei Han
Journal:  Adv Pharmacol       Date:  2013

4.  TSLP signaling network revealed by SILAC-based phosphoproteomics.

Authors:  Jun Zhong; Min-Sik Kim; Raghothama Chaerkady; Xinyan Wu; Tai-Chung Huang; Derese Getnet; Christopher J Mitchell; Shyam M Palapetta; Jyoti Sharma; Robert N O'Meally; Robert N Cole; Akinori Yoda; Albrecht Moritz; Marc M Loriaux; John Rush; David M Weinstock; Jeffrey W Tyner; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2012-02-16       Impact factor: 5.911

Review 5.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

6.  Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; Michelle Y Doral; Michael J Borowitz; Brent L Wood; I-Ming Chen; Richard C Harvey; Julie M Gastier-Foster; Cheryl L Willman; Stephen P Hunger; Charles G Mullighan; Mignon L Loh
Journal:  Blood       Date:  2012-06-08       Impact factor: 22.113

7.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Ryan D Morin; Jinghui Zhang; Martin Hirst; Yongjun Zhao; Xiaoping Su; Shann-Ching Chen; Debbie Payne-Turner; Michelle L Churchman; Richard C Harvey; Xiang Chen; Corynn Kasap; Chunhua Yan; Jared Becksfort; Richard P Finney; David T Teachey; Shannon L Maude; Kane Tse; Richard Moore; Steven Jones; Karen Mungall; Inanc Birol; Michael N Edmonson; Ying Hu; Kenneth E Buetow; I-Ming Chen; William L Carroll; Lei Wei; Jing Ma; Maria Kleppe; Ross L Levine; Guillermo Garcia-Manero; Eric Larsen; Neil P Shah; Meenakshi Devidas; Gregory Reaman; Malcolm Smith; Steven W Paugh; William E Evans; Stephan A Grupp; Sima Jeha; Ching-Hon Pui; Daniela S Gerhard; James R Downing; Cheryl L Willman; Mignon Loh; Stephen P Hunger; Marco A Marra; Charles G Mullighan
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

8.  A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.

Authors:  Olivia L Francis; Terry-Ann M Milford; Shannalee R Martinez; Ineavely Baez; Jacqueline S Coats; Karina Mayagoitia; Katherine R Concepcion; Elizabeth Ginelli; Cornelia Beldiman; Abigail Benitez; Abby J Weldon; Keshav Arogyaswamy; Parveen Shiraz; Ross Fisher; Christopher L Morris; Xiao-Bing Zhang; Valeri Filippov; Ben Van Handel; Zheng Ge; Chunhua Song; Sinisa Dovat; Ruijun Jeanna Su; Kimberly J Payne
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941

9.  Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target.

Authors:  Tai-Chung Huang; Jevon Cutler; Shubhada Bharne; Jun Zhong; David Weinstock; Jeffrey Tyner; Ivana Gojo; Curt Civin; Akhilesh Pandey
Journal:  Leuk Lymphoma       Date:  2014-11-05

Review 10.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.